Zai Lab
Zai Lab is an innovative, research-based, commercial-stage biopharmaceutical company based in China and the United States, founded in 2014 with headquarters in Cambridge, Massachusetts and Shanghai. The company discovers, develops, and commercializes transformative medicines for conditions with significant unmet patient needs across oncology, immunology, neuroscience, and infectious disease. As a fully integrated biopharma, Zai Lab spans early-stage discovery through development, regulatory approval, manufacturing, and commercialization. It was surfaced in the API Evangelist network as a portfolio company of HongShan and Qiming Venture Partners. Zai Lab publishes a corporate and investor web presence but exposes no public developer API surface.
Zai Lab is profiled on the APIs.io network. Tagged areas include Company, Healthcare, Biopharmaceutical, Oncology, and Immunology.
Zai Lab’s developer surface includes engineering blog, support, and 5 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 3
The organization behind the API